Everest Medicines Liabilities 2024

Liabilities Details

Assessing Everest Medicines's Liabilities

Everest Medicines's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Everest Medicines's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Everest Medicines's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Everest Medicines's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Everest Medicines’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Everest Medicines stock

What is the level of liabilities of Everest Medicines this year?

Everest Medicines has a debt balance of 804.1 M CNY this year.

What were the liabilities of Everest Medicines compared to the previous year?

The liabilities of Everest Medicines have increased by -16.26% dropped compared to the previous year.

What are the consequences of high debt for investors of Everest Medicines?

High liabilities can pose a risk for investors of Everest Medicines, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Everest Medicines?

Low liabilities mean that Everest Medicines has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Everest Medicines affect the company?

An increase in liabilities of Everest Medicines can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Everest Medicines affect the company?

A decrease in the liabilities of Everest Medicines can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Everest Medicines?

Some factors that can influence the liabilities of Everest Medicines include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Everest Medicines so important for investors?

The liabilities of Everest Medicines are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Everest Medicines take to modify the liabilities?

To change its liabilities, Everest Medicines can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Everest Medicines pay?

Over the past 12 months, Everest Medicines paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Everest Medicines is expected to pay a dividend of 0 CNY.

What is the dividend yield of Everest Medicines?

The current dividend yield of Everest Medicines is .

When does Everest Medicines pay dividends?

Everest Medicines pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Everest Medicines?

Everest Medicines paid dividends every year for the past 0 years.

What is the dividend of Everest Medicines?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Everest Medicines located?

Everest Medicines is assigned to the 'Health' sector.

Wann musste ich die Aktien von Everest Medicines kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Everest Medicines from 8/9/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 8/9/2024.

When did Everest Medicines pay the last dividend?

The last dividend was paid out on 8/9/2024.

What was the dividend of Everest Medicines in the year 2023?

In the year 2023, Everest Medicines distributed 0 CNY as dividends.

In which currency does Everest Medicines pay out the dividend?

The dividends of Everest Medicines are distributed in CNY.